These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 23455521)
1. The value of 18F-FLT PET for detecting second primary cancers and distant metastases in head and neck cancer patients. Hoshikawa H; Kishino T; Mori T; Nishiyama Y; Yamamoto Y; Mori N Clin Nucl Med; 2013 Aug; 38(8):e318-23. PubMed ID: 23455521 [TBL] [Abstract][Full Text] [Related]
2. Comparison of ( 18 ) F-FLT PET and ( 18 ) F-FDG PET for detection of cervical lymph node metastases in head and neck cancers. Hoshikawa H; Kishino T; Mori T; Nishiyama Y; Yamamoto Y; Inamoto R; Akiyama K; Mori N Acta Otolaryngol; 2012 Dec; 132(12):1347-54. PubMed ID: 22992199 [TBL] [Abstract][Full Text] [Related]
3. 18F-FLT PET does not discriminate between reactive and metastatic lymph nodes in primary head and neck cancer patients. Troost EG; Vogel WV; Merkx MA; Slootweg PJ; Marres HA; Peeters WJ; Bussink J; van der Kogel AJ; Oyen WJ; Kaanders JH J Nucl Med; 2007 May; 48(5):726-35. PubMed ID: 17475960 [TBL] [Abstract][Full Text] [Related]
4. Usefulness of 3'-deoxy-3'-18F-fluorothymidine PET for predicting early response to chemoradiotherapy in head and neck cancer. Kishino T; Hoshikawa H; Nishiyama Y; Yamamoto Y; Mori N J Nucl Med; 2012 Oct; 53(10):1521-7. PubMed ID: 22872738 [TBL] [Abstract][Full Text] [Related]
5. Diagnosis of metastases from postoperative differentiated thyroid cancer: comparison between FDG and FLT PET/CT studies. Nakajo M; Nakajo M; Jinguji M; Tani A; Kajiya Y; Tanabe H; Fukukura Y; Nakabeppu Y; Koriyama C Radiology; 2013 Jun; 267(3):891-901. PubMed ID: 23468571 [TBL] [Abstract][Full Text] [Related]
6. FDG-PET and detection of distant metastases and simultaneous tumors in head and neck squamous cell carcinoma: a comparison with chest radiography and chest CT. Krabbe CA; Pruim J; van der Laan BF; Rödiger LA; Roodenburg JL Oral Oncol; 2009 Mar; 45(3):234-40. PubMed ID: 18715818 [TBL] [Abstract][Full Text] [Related]
7. Combined 18F-fluorodeoxyglucose-positron emission tomography and computed tomography as a primary screening method for detecting second primary cancers and distant metastases in patients with head and neck cancer. Kim SY; Roh JL; Yeo NK; Kim JS; Lee JH; Choi SH; Nam SY Ann Oncol; 2007 Oct; 18(10):1698-703. PubMed ID: 17716985 [TBL] [Abstract][Full Text] [Related]
8. 18F-FLT PET/CT imaging is not competent for the pretreatment evaluation of metastatic gastric cancer: a comparison with 18F-FDG PET/CT imaging. Zhou M; Wang C; Hu S; Zhang Y; Yao Z; Li J; Guo W; Zhang Y Nucl Med Commun; 2013 Jul; 34(7):694-700. PubMed ID: 23604223 [TBL] [Abstract][Full Text] [Related]
9. Changes in (18)F-fluorothymidine and (18)F-fluorodeoxyglucose positron emission tomography imaging in patients with head and neck cancer treated with chemoradiotherapy. Hoshikawa H; Mori T; Kishino T; Yamamoto Y; Inamoto R; Akiyama K; Mori N; Nishiyama Y Ann Nucl Med; 2013 May; 27(4):363-70. PubMed ID: 23378102 [TBL] [Abstract][Full Text] [Related]
10. Can 3'-Deoxy-3'-((18)F) Fluorothymidine Out Perform 2-Deoxy-2-((18)F) Fluoro-D-Glucose Positron Emission Tomography/Computed Tomography in the Diagnosis of Cervical Lymphadenopathy in Patients With Oral/Head and Neck Cancer? Schaefferkoetter JD; Carlson ER; Heidel RE J Oral Maxillofac Surg; 2015 Jul; 73(7):1420-8. PubMed ID: 25869746 [TBL] [Abstract][Full Text] [Related]
11. Comparison of the diagnostic value of 3-deoxy-3-18F-fluorothymidine and 18F-fluorodeoxyglucose positron emission tomography/computed tomography in the assessment of regional lymph node in thoracic esophageal squamous cell carcinoma: a pilot study. Han D; Yu J; Zhong X; Fu Z; Mu D; Zhang B; Xu G; Yang W; Zhao S Dis Esophagus; 2012 Jul; 25(5):416-26. PubMed ID: 21951837 [TBL] [Abstract][Full Text] [Related]
12. Prognostic value comparison between (18)F-FLT PET/CT and (18)F-FDG PET/CT volume-based metabolic parameters in patients with head and neck cancer. Hoshikawa H; Mori T; Yamamoto Y; Kishino T; Fukumura T; Samukawa Y; Mori N; Nishiyama Y Clin Nucl Med; 2015 Jun; 40(6):464-8. PubMed ID: 25546204 [TBL] [Abstract][Full Text] [Related]
13. Screening for distant metastases in patients with head and neck cancer: is there a role for (18)FDG-PET? Brouwer J; Senft A; de Bree R; Comans EF; Golding RP; Castelijns JA; Hoekstra OS; Leemans CR Oral Oncol; 2006 Mar; 42(3):275-80. PubMed ID: 16266820 [TBL] [Abstract][Full Text] [Related]
14. Comparison of FLT-PET and FDG-PET for visualization of head and neck squamous cell cancers. Hoshikawa H; Nishiyama Y; Kishino T; Yamamoto Y; Haba R; Mori N Mol Imaging Biol; 2011 Feb; 13(1):172-7. PubMed ID: 20464518 [TBL] [Abstract][Full Text] [Related]
15. Evaluation of head and neck cancer with 18F-FDG PET: a comparison with conventional methods. Kresnik E; Mikosch P; Gallowitsch HJ; Kogler D; Wiesser S; Heinisch M; Unterweger O; Raunik W; Kumnig G; Gomez I; Grünbacher G; Lind P Eur J Nucl Med; 2001 Jul; 28(7):816-21. PubMed ID: 11504077 [TBL] [Abstract][Full Text] [Related]
16. Comparison of 18F-FLT PET and 18F-FDG PET in esophageal cancer. van Westreenen HL; Cobben DC; Jager PL; van Dullemen HM; Wesseling J; Elsinga PH; Plukker JT J Nucl Med; 2005 Mar; 46(3):400-4. PubMed ID: 15750150 [TBL] [Abstract][Full Text] [Related]
17. Uptake of (18)F-FLT and (18)F-FDG in primary head and neck cancer correlates with survival. Linecker A; Kermer C; Sulzbacher I; Angelberger P; Kletter K; Dudczak R; Ewers R; Becherer A Nuklearmedizin; 2008; 47(2):80-5; quiz N12. PubMed ID: 18392317 [TBL] [Abstract][Full Text] [Related]
18. 18F fluorodeoxyglucose PET/CT in head and neck squamous cell carcinoma with negative neck palpation findings: a prospective study. Roh JL; Park JP; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY Radiology; 2014 Apr; 271(1):153-61. PubMed ID: 24475791 [TBL] [Abstract][Full Text] [Related]
19. 18F-fluorodeoxyglucose positron emission tomography to evaluate cervical node metastases in patients with head and neck squamous cell carcinoma: a meta-analysis. Kyzas PA; Evangelou E; Denaxa-Kyza D; Ioannidis JP J Natl Cancer Inst; 2008 May; 100(10):712-20. PubMed ID: 18477804 [TBL] [Abstract][Full Text] [Related]